🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 16 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/02/1998 | 48,66 | 48,66 | 47,72 | 48,19 | +0,00% | 1,92% | 95.779 |
| 06/02/1998 | 43,04 | 50,53 | 43,04 | 48,19 | +14,44% | 17,39% | 257.896 |
| 05/02/1998 | 42,58 | 42,58 | 41,64 | 42,11 | -0,55% | 2,20% | 86.883 |
| 04/02/1998 | 42,58 | 42,58 | 41,87 | 42,34 | +0,00% | 1,65% | 58.162 |
| 03/02/1998 | 41,64 | 42,58 | 41,64 | 42,34 | +1,69% | 2,25% | 108.336 |
| 02/02/1998 | 42,11 | 43,04 | 41,41 | 41,64 | +1,14% | 3,89% | 85.199 |
| 30/01/1998 | 41,64 | 42,58 | 40,94 | 41,17 | +0,00% | 3,93% | 189.475 |
| 29/01/1998 | 44,21 | 44,45 | 40,70 | 41,17 | -6,88% | 8,47% | 125.622 |
| 28/01/1998 | 44,68 | 44,92 | 43,98 | 44,21 | -1,05% | 2,09% | 19.476 |
| 27/01/1998 | 44,68 | 44,92 | 43,92 | 44,68 | +0,00% | 2,23% | 53.487 |
| 26/01/1998 | 45,62 | 46,32 | 44,45 | 44,68 | -2,05% | 4,10% | 92.627 |
| 23/01/1998 | 47,26 | 48,19 | 45,38 | 45,62 | -4,41% | 5,94% | 70.131 |
| 22/01/1998 | 46,79 | 47,72 | 46,32 | 47,72 | +2,00% | 3,00% | 40.609 |
| 21/01/1998 | 48,19 | 48,19 | 46,32 | 46,79 | -0,99% | 3,88% | 31.446 |
| 20/01/1998 | 45,85 | 47,72 | 45,85 | 47,26 | +3,06% | 4,08% | 53.353 |
| 16/01/1998 | 45,85 | 46,79 | 45,38 | 45,85 | +1,03% | 3,06% | 144.938 |
| 15/01/1998 | 45,85 | 45,85 | 44,92 | 45,38 | -1,02% | 2,04% | 408.658 |
| 14/01/1998 | 45,15 | 45,85 | 44,92 | 45,85 | +2,08% | 2,07% | 65.750 |
| 13/01/1998 | 44,92 | 45,38 | 44,45 | 44,92 | +1,05% | 2,08% | 39.701 |
| 12/01/1998 | 44,45 | 45,38 | 43,98 | 44,45 | -3,06% | 3,16% | 41.037 |
| 09/01/1998 | 46,09 | 47,26 | 44,92 | 45,85 | -2,00% | 5,08% | 128.988 |
| 08/01/1998 | 47,72 | 48,19 | 46,67 | 46,79 | -3,38% | 3,19% | 69.089 |
| 07/01/1998 | 48,89 | 48,89 | 48,19 | 48,42 | -0,96% | 1,44% | 39.407 |
| 06/01/1998 | 50,30 | 50,30 | 48,42 | 48,89 | -2,34% | 3,72% | 61.128 |
| 05/01/1998 | 47,72 | 50,06 | 47,72 | 50,06 | +4,90% | 4,90% | 85.921 |
| 02/01/1998 | 48,42 | 49,13 | 46,79 | 47,72 | -0,97% | 4,83% | 26.369 |
| 31/12/1997 | 46,79 | 48,66 | 46,55 | 48,19 | +3,52% | 4,50% | 100.268 |
| 30/12/1997 | 45,85 | 46,79 | 45,38 | 46,55 | +3,11% | 3,06% | 55.036 |
| 29/12/1997 | 45,38 | 46,32 | 44,92 | 45,15 | +0,52% | 3,09% | 67.139 |
| 26/12/1997 | 44,45 | 44,92 | 43,51 | 44,92 | +3,23% | 3,16% | 14.000 |